Skip to main content
| News

InOpSys heading to Basel

01.02.2022

The Belgian company InOpSys is opening a subsidiary in Basel. The supplier of water purification solutions intends to press on with its European expansion plans from its new Swiss base.

Working environment of InOpSys (img: InOpSys)

InOpSys NV has founded a new subsidiary in the form of InOpSys GmbH, which is to be based in Basel. The Belgian cleantech company with offices in Mechelen and Antwerp has its sights set on growing across Europe and is targeting the Swiss, German, Irish and French markets as a starting point for this aim. Basel’s favorable geographical location, its abundance of highly qualified experts and the awareness of sustainability across Switzerland, among other aspects, were decisive factors behind the choice of location. In addition, the investment and innovation promotion agency Basel Area Business & Innovation has supported the process of establishing the business in the region. (read more about starting a business in Switzerland)

Strategic industry partner in the Basel Area

InOpSys GmbH will now seek to bring on board employees in the areas of sales, research and development, engineering and operations. In so doing, the cleantech firm is aiming to position itself to offer its services to the life sciences industry. In essence, InOpSys purifies water. However, its focus is on water volumes that were previously disposed of as wastewater after purification. After all, this water still contains valuable raw materials such as metals. InOpSys has developed a chemical solution to clean this water as well. As such, the raw materials obtained in this way can then be reused, while the additional clean water left over can also be put to good use. In this way, water and resources are returned to the cycle and do not have to be disposed of as has been the case up to now. For this purpose, InOpSys has developed mobile and modular units that are used on site.

According to Steven De Laet, CEO of InOpSys, the company has “developed innovative and sustainable solutions” that help customers to cut waste, minimize their carbon footprint and implement circular economy measures. “Now we aim to grow InOpSys GmbH and to become a strategic industry partner in the Basel Area and other core cities in Switzerland”, he adds.

 

Learn what it’s like to work in Switzerland, what permits you need as a foreign worker and how to find work here. Check out our working in Switzerland page for more info.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

Advanced Manufacturing/AI, Basel Area Business & Innovation, Innovation, Invest, Sustainability

KUORI developing biodegradable plastics

The Basel-based cleantech company KUORI GmbH develops alternative materials for conventional plastics. The aim is to reduce the accumulation of...

Read More
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Cell and gene therapies gain momentum in Basel

Companies specializing in the research and development of innovative cell and gene therapies continue to spring up all around the...

Read More
BLKB expanding support for startups
Basel Area Business & Innovation, Innovation, Invest

BLKB expanding support for startups

BLKB offers particularly promising SMEs and startups financial support within the framework of the “100 fürs Baselbiet” program. These companies...

Read More
Combatting the rise of antimicrobial resistance
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Combatting the rise of antimicrobial resistance

Antimicrobial resistance (AMR) is a growing global threat that, without intervention, could lead to as many as 10 million deaths...

Read More
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

AMR Action Fund invests in new antibiotics developed by BioVersys

The AMR Action Fund has made its first European investment in BioVersys, which is headquartered at Tech Park Basel. The...

Read More
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Investors give Resistell 8.5 million Swiss francs

Resistell AG has secured 8.5 million Swiss francs in the first part of its series B funding round. The biotechnology...

Read More
1 2 3 60

Do you have a question? We'd like to hear from you.